177 related articles for article (PubMed ID: 37016431)
21. Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
Antić Ž; Yu J; Bornhauser BC; Lelieveld SH; van der Ham CG; van Reijmersdal SV; Morgado L; Elitzur S; Bourquin JP; Cazzaniga G; Eckert C; Camós M; Sutton R; Cavé H; Moorman AV; Sonneveld E; Geurts van Kessel A; van Leeuwen FN; Hoogerbrugge PM; Waanders E; Kuiper RP
Pediatr Blood Cancer; 2022 Jan; 69(1):e29361. PubMed ID: 34597466
[TBL] [Abstract][Full Text] [Related]
22. Recruitment of FBXO22 for Targeted Degradation of NSD2.
Nie DY; Tabor JR; Li J; Kutera M; St-Germain J; Hanley RP; Wolf E; Paulakonis E; Kenney TMG; Duan S; Shrestha S; Owens DDG; Pon A; Szewczyk M; Lamberto AJ; Menes M; Li F; Barsyte-Lovejoy D; Brown NG; Barsotti AM; Stamford AW; Collins JL; Wilson DJ; Raught B; Licht JD; James LI; Arrowsmith CH
bioRxiv; 2023 Nov; ():. PubMed ID: 37961297
[TBL] [Abstract][Full Text] [Related]
23. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.
Oyer JA; Huang X; Zheng Y; Shim J; Ezponda T; Carpenter Z; Allegretta M; Okot-Kotber CI; Patel JP; Melnick A; Levine RL; Ferrando A; Mackerell AD; Kelleher NL; Licht JD; Popovic R
Leukemia; 2014 Jan; 28(1):198-201. PubMed ID: 23823660
[No Abstract] [Full Text] [Related]
24. The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription.
Kang HB; Choi Y; Lee JM; Choi KC; Kim HC; Yoo JY; Lee YH; Yoon HG
FEBS Lett; 2009 Jun; 583(12):1880-6. PubMed ID: 19481544
[TBL] [Abstract][Full Text] [Related]
25. Posttranslational modification of Aurora A-NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma.
Jiang H; Wang Y; Wang J; Wang Y; Wang S; He E; Guo J; Xie Y; Wang J; Li X; Peng Z; Wang M; Hou J; Liu Z
Clin Transl Med; 2022 Apr; 12(4):e744. PubMed ID: 35389552
[TBL] [Abstract][Full Text] [Related]
26. The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.
Tanaka H; Igata T; Etoh K; Koga T; Takebayashi SI; Nakao M
Aging Cell; 2020 Jul; 19(7):e13173. PubMed ID: 32573059
[TBL] [Abstract][Full Text] [Related]
27. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
28. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
[TBL] [Abstract][Full Text] [Related]
29. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
30. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
[TBL] [Abstract][Full Text] [Related]
31. Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia.
Sayyab S; Lundmark A; Larsson M; Ringnér M; Nystedt S; Marincevic-Zuniga Y; Tamm KP; Abrahamsson J; Fogelstrand L; Heyman M; Norén-Nyström U; Lönnerholm G; Harila-Saari A; Berglund EC; Nordlund J; Syvänen AC
Sci Rep; 2021 Aug; 11(1):15988. PubMed ID: 34362951
[TBL] [Abstract][Full Text] [Related]
32. Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation.
Park JW; Kang JY; Hahm JY; Kim HJ; Seo SB
Commun Biol; 2020 Aug; 3(1):462. PubMed ID: 32826945
[TBL] [Abstract][Full Text] [Related]
33. H3K36me2 methyltransferase NSD2 orchestrates epigenetic reprogramming during spermatogenesis.
Li Z; Zhang X; Xie S; Liu X; Fei C; Huang X; Tang Y; Zhou LQ
Nucleic Acids Res; 2022 Jul; 50(12):6786-6800. PubMed ID: 35736136
[TBL] [Abstract][Full Text] [Related]
34. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
Waanders E; Gu Z; Dobson SM; Antić Ž; Crawford JC; Ma X; Edmonson MN; Payne-Turner D; van de Vorst M; Jongmans MCJ; McGuire I; Zhou X; Wang J; Shi L; Pounds S; Pei D; Cheng C; Song G; Fan Y; Shao Y; Rusch M; McCastlain K; Yu J; van Boxtel R; Blokzijl F; Iacobucci I; Roberts KG; Wen J; Wu G; Ma J; Easton J; Neale G; Olsen SR; Nichols KE; Pui CH; Zhang J; Evans WE; Relling MV; Yang JJ; Thomas PG; Dick JE; Kuiper RP; Mullighan CG
Blood Cancer Discov; 2020 Jul; 1(1):96-111. PubMed ID: 32793890
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
Mullighan CG; Phillips LA; Su X; Ma J; Miller CB; Shurtleff SA; Downing JR
Science; 2008 Nov; 322(5906):1377-80. PubMed ID: 19039135
[TBL] [Abstract][Full Text] [Related]
36. Remodeling of the 3D chromatin architecture in the marine microalga Nannochloropsis oceanica during lipid accumulation.
Yan T; Wang K; Feng K; Gao X; Jin Y; Wu H; Zhang W; Wei L
Biotechnol Biofuels Bioprod; 2023 Aug; 16(1):129. PubMed ID: 37592325
[TBL] [Abstract][Full Text] [Related]
37. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
Folgiero V; Sorino C; Pallocca M; De Nicola F; Goeman F; Bertaina V; Strocchio L; Romania P; Pitisci A; Iezzi S; Catena V; Bruno T; Strimpakos G; Passananti C; Mattei E; Blandino G; Locatelli F; Fanciulli M
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29367285
[TBL] [Abstract][Full Text] [Related]
38. Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice.
Kinoshita S; Kojima K; Ohnishi E; Takayama Y; Kikuchi H; Takada S; Nakabayashi K; Kawai T; Hata K
Front Genet; 2024; 15():1308234. PubMed ID: 38419783
[No Abstract] [Full Text] [Related]
39. Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.
Kiss R; Gángó A; Benard-Slagter A; Egyed B; Haltrich I; Hegyi L; de Groot K; Király PA; Krizsán S; Kajtár B; Pikó H; Pajor L; Vojcek Á; Matolcsy A; Kovács G; Szuhai K; Savola S; Bödör C; Alpár D
Mod Pathol; 2020 May; 33(5):812-824. PubMed ID: 31857684
[TBL] [Abstract][Full Text] [Related]
40. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
